Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2002-11-30
2005-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Aims
* To develop a deeper understanding of Cerebral Blood Flow and auto-regulation for TBI patients based on the results of data collected in patients post TBI.
* To establish the basis for further multi modality clinical trials in severely brain injured patients in the future.
* To improve understanding of the various secondary processes that continue to cause neuronal damage after the initial injury, and therefore affect patient outcome.
* To proceed to the second phase of the study, with the introduction of algorithms for treatment.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We aim to:
* further clarify what the above mentioned relationships between monitoring parameters are, what are the most critical ones and the effect that optimisation of these parameters has on brain swelling, ICP control and on clinical outcome.
* introduce treatment algorithms/protocols to alter the haemodynamic parameters, CPP and ICP and to optimise PbrO2.
* study the patients having decompressive craniectomy using these techniques where possible
* compare patient outcomes to previous outcome studies at the Alfred Hospital.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Brain oxygenation and microdialysis catheters
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Traumatic Brain Injury with a Glascow Coma Score \> 8 with an intracranial pressure monitor in situ and CTscan evidence of one or more of the following: Cerebral oedema (Marshall grades III \& IV), midline shift \>5 mm cerebral contusion \>3cm, evacuated subdural haematoma
* Enrolled within the first 48 hours after trauma
* Aged 17- 70years
Exclusion Criteria
* Pupils are fixed bilaterally and dilated \>4mm,GCS=3
* Coagulopathy sufficient to contraindicate surgery
* No chance of survival after consideration of CT and clinical findings
* Patients with lower limb/pelvic trauma excluded from Innercool monitoring only
17 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bayside Health
OTHER_GOV
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas Kossmann, Professor
Role: PRINCIPAL_INVESTIGATOR
The Alfred
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Alfred Hospital
Melbourne, Victoria, Australia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
145/02
Identifier Type: -
Identifier Source: org_study_id